DE3587596T2 - Pyridazinon-Derivate, deren Herstellung und Verwendung. - Google Patents

Pyridazinon-Derivate, deren Herstellung und Verwendung.

Info

Publication number
DE3587596T2
DE3587596T2 DE89105964T DE3587596T DE3587596T2 DE 3587596 T2 DE3587596 T2 DE 3587596T2 DE 89105964 T DE89105964 T DE 89105964T DE 3587596 T DE3587596 T DE 3587596T DE 3587596 T2 DE3587596 T2 DE 3587596T2
Authority
DE
Germany
Prior art keywords
sup
production
pyridazinone derivatives
variety
potentiate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89105964T
Other languages
English (en)
Other versions
DE3587596D1 (de
Inventor
Yasuhiro Morisawa
Mitsuru Kataoka
Seiji Kumakura
Hiroyuki Koike
Shinsaku Kobayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of DE3587596D1 publication Critical patent/DE3587596D1/de
Publication of DE3587596T2 publication Critical patent/DE3587596T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
DE89105964T 1984-10-12 1985-10-14 Pyridazinon-Derivate, deren Herstellung und Verwendung. Expired - Fee Related DE3587596T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59213968A JPS6193169A (ja) 1984-10-12 1984-10-12 ピリダジノン誘導体及びその製法

Publications (2)

Publication Number Publication Date
DE3587596D1 DE3587596D1 (de) 1993-10-28
DE3587596T2 true DE3587596T2 (de) 1994-05-11

Family

ID=16648043

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8585307364T Expired - Fee Related DE3581465D1 (de) 1984-10-12 1985-10-14 Pyridazinonderivate, deren herstellung und verwendung.
DE89105964T Expired - Fee Related DE3587596T2 (de) 1984-10-12 1985-10-14 Pyridazinon-Derivate, deren Herstellung und Verwendung.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE8585307364T Expired - Fee Related DE3581465D1 (de) 1984-10-12 1985-10-14 Pyridazinonderivate, deren herstellung und verwendung.

Country Status (7)

Country Link
US (1) US4914093A (de)
EP (2) EP0330242B1 (de)
JP (1) JPS6193169A (de)
KR (1) KR900002059B1 (de)
AT (2) ATE60324T1 (de)
DE (2) DE3581465D1 (de)
ES (1) ES8702371A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0613483B2 (ja) * 1985-11-12 1994-02-23 三共株式会社 フエニルピリダジノン誘導体
JPS6314774A (ja) * 1986-07-07 1988-01-21 Mitsubishi Chem Ind Ltd ピリダジノン誘導体又はその塩類
US4888423A (en) * 1986-10-06 1989-12-19 Ciba-Geigy Corporation 6-(4-Hydroxyphenyl)-4,5-dihydro-3(2h)-pyridazinones and stabilized compositions
US5019612A (en) * 1986-10-06 1991-05-28 Ciba-Geigy Corporation 6-(4-hydroxyphenyl)-4,5-dihydro-3(2H)-pyridazinones and stabilized compositions
DE3728491A1 (de) * 1987-08-26 1989-03-09 Heumann Pharma Gmbh & Co Dihydropyridazinon-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5198448A (en) * 1988-08-10 1993-03-30 Otsuka Pharmaceutical Company, Limited Cardiotonics
DE3902316A1 (de) * 1989-01-26 1990-08-02 Lentia Gmbh Neue piperazinylalkyl-3(2h)-pyridazinone, verfahren zu ihrer herstellung und ihre verwendung als blutdrucksenkende mittel
US5273976A (en) * 1989-04-06 1993-12-28 Sankyo Company, Limited Ocular hypotensive agents
US5175161A (en) * 1989-04-06 1992-12-29 Sankyo Company, Limited Occular hypotensive agents
EP0412814A3 (en) * 1989-08-10 1991-07-24 Glaxo Inc. Pyridazinones having cardiotonic and beta blocking activity
US5204463A (en) * 1989-08-10 1993-04-20 Glaxo Inc. Substituted methoxyphenyl-4,5 dihydro-3(2H)-pridazinones having cardiotonic and beta blocking activities
US5096904A (en) * 1989-09-01 1992-03-17 Glaxo Inc. Pyridazinones having cardiotonic and beta blocking activities
US5051431A (en) * 1989-09-22 1991-09-24 Glaxo Inc. Pyridone nitriles useful in treating cardiovascular disease
US5153209A (en) * 1989-09-22 1992-10-06 Glaxo Inc. Pyridone nitriles useful in treating cardiovascular disease
US5100892A (en) * 1990-11-13 1992-03-31 Glaxo Inc. Dihydropyridine vasodilator agents
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
IL118631A (en) * 1995-06-27 2002-05-23 Tanabe Seiyaku Co History of pyridazinone and processes for their preparation
EP1565472A2 (de) * 2002-11-27 2005-08-24 Artesian Therapeutics, Inc. Verbindungen mit gemischtem pde- hemmendem und beta-adrenergischem antagonisten oder partiellagonisten- wirkung zur behandlung der herzinsuffizienz
JP2006513222A (ja) * 2002-12-23 2006-04-20 アルテシアン セラピューティック，インコーポレイティド アドレナリン性β受容体およびホスホジエステラーゼに対する抑制活性を有する強心性化合物
JP2008521805A (ja) * 2004-11-30 2008-06-26 アーテシアン セラピューティクス， インコーポレイテッド β−アドレナリン作用性受容体およびホスホジエステラーゼに対する阻害活性を有する強心性化合物
WO2006060127A2 (en) * 2004-11-30 2006-06-08 Artesian Therapeutics, Inc. COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE
JP2006181097A (ja) * 2004-12-27 2006-07-13 Mammy's:Kk 売り場構造及び商品陳列方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1383906A (en) * 1971-02-22 1974-02-12 Bdh Pharmaceuticals Ltd Pyridazinones
GB1488330A (en) * 1973-12-19 1977-10-12 Smith Kline French Lab Dihydropyridazinones
JPS588015A (ja) * 1981-07-06 1983-01-18 Mitsubishi Chem Ind Ltd 強心剤
US4816454A (en) * 1984-09-21 1989-03-28 Cassella Aktiengesellschaft 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use

Also Published As

Publication number Publication date
EP0330242B1 (de) 1993-09-22
JPH0557983B2 (de) 1993-08-25
ATE60324T1 (de) 1991-02-15
EP0330242A1 (de) 1989-08-30
ATE94874T1 (de) 1993-10-15
JPS6193169A (ja) 1986-05-12
US4914093A (en) 1990-04-03
DE3581465D1 (de) 1991-02-28
EP0178189A3 (en) 1987-03-04
EP0178189A2 (de) 1986-04-16
KR860003232A (ko) 1986-05-21
KR900002059B1 (ko) 1990-03-31
DE3587596D1 (de) 1993-10-28
EP0178189B1 (de) 1991-01-23
ES547826A0 (es) 1986-12-16
ES8702371A1 (es) 1986-12-16

Similar Documents

Publication Publication Date Title
DE3587596T2 (de) Pyridazinon-Derivate, deren Herstellung und Verwendung.
ATE40884T1 (de) Zwischenverbindungen fuer die herstellung von omeprazol.
ATE90092T1 (de) Thiazolidinon-derivate, ihre herstellung und ihre verwendung.
EP0262399A3 (en) Cyclic enol derivatives, production and use thereof
ATE102930T1 (de) Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend.
DE3576957D1 (de) Carbapenemverbindungen, deren herstellung und verwendung.
DE3775666D1 (de) Hydroxybutenolid-derivate, ihre herstellung und ihre verwendung.
ATE66476T1 (de) Thianaphthen-derivate, ihre herstellung und verwendung.
EP0159040A3 (en) Pyridine derivatives and production thereof
MY110092A (en) Butyric acid derivatives
FI870460A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5-substituerade oktahydroindolizinderivat och vid foerfarandet anvaendbara mellanprodukter.
ATE104967T1 (de) Imidazolderivate, deren herstellung und therapeutische verwendung.
ATE64921T1 (de) Benzochinonderivate, ihre herstellung und verwendung.
DE69106008T2 (de) Behandlung von Schlaf-Apnoea mit Azapironderivaten.
DE3666430D1 (en) Condensed seven-membered heterocyclic compounds, their production and use
BE903755A (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments.
SE7613426L (sv) Blandade estrar av polyoler
ATE160567T1 (de) Psoralen-derivate, deren herstellung und verwendung als arzneimittel
ATE22298T1 (de) 6-beta,7-beta-methylen-17-alpha-pregn-4-ene-21carbolaktone, ihre herstellung und anwendung als arzneimittel.
FI842639A (fi) Acylderivat av 1,4,3,6-dianhydro- hexitol.
FR2573428B1 (fr) Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent
TH3409A (th) อนุพันธ์ของซัคคารินที่เติมหมู่เอซิลแล้ว
TH13948EX (th) อนุพันธ์ของพิริดิลไธอะโซลิดีนคาร์บอกซิลิค แอซิด แอมีด, การเตรียมและการใช้สารเหล่านั้นในการรักษา

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee